CompletedNot Applicable

The Impact of Body Mass Index on the Endometrial Microbiome in IVF Treatments. Tampere Infertility Microbiome Project (TIMP).

Finland91 participantsStarted 2020-08-14

Plain-language summary

This study project is an observational trial involving 90 patients suffering from male type infertility. The patients are divided in two groups (45 patients per group) based on their body mass index (BMI).

Who can participate

Age range20 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with male infertility scheduled for IVF treatment and fresh embryo transfer * Primary or secondary male-type infertility * BMI over 30 kg/m² or under 25 kg/m² * Patient's willingness to participate Exclusion Criteria: * Patients with endometriosis or adenomyosis * Use of antibiotics during IVF treatment or oocyte retrieval * Technical diffuculties in embryo transfer or no embryos available for transfer

What they're measuring

Microbiome variety between groups

Timeframe: through study completion, 1-2 years from the starting date

Trial details

NCT IDNCT04168567

SponsorTampere University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-01

View on ClinicalTrials.gov More Infertility, Female trials